CGON
Counsel to CG Oncology for common stock offering valued up to $500M
CG Oncology engaged legal counsel for an Offering of Shares pursuant to an Open Market Sale Agreement. As a biopharma developer of drugs for urothelial cancer, successful capital raising is crucial for growth.